Surgery Partners, Inc. $SGRY Stock Holdings Decreased by Hsbc Holdings PLC

Hsbc Holdings PLC reduced its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 54.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,385 shares of the company’s stock after selling 14,797 shares during the quarter. Hsbc Holdings PLC’s holdings in Surgery Partners were worth $295,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. PNC Financial Services Group Inc. boosted its holdings in shares of Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock worth $28,000 after purchasing an additional 542 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Surgery Partners during the first quarter worth approximately $31,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Surgery Partners during the first quarter worth approximately $65,000. State of Wyoming boosted its holdings in shares of Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company’s stock worth $85,000 after purchasing an additional 1,943 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock worth $91,000 after purchasing an additional 465 shares during the period.

Insider Transactions at Surgery Partners

In related news, Director Teresa Deluca sold 20,018 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the transaction, the director owned 45,173 shares of the company’s stock, valued at approximately $1,027,234.02. The trade was a 30.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 2.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Barclays decreased their price target on shares of Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating for the company in a report on Tuesday, May 27th. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a “buy” rating and a $28.00 price target for the company. Six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $33.00.

Surgery Partners Stock Performance

SGRY stock opened at $22.51 on Thursday. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $2.89 billion, a price-to-earnings ratio of -15.74 and a beta of 1.76. Surgery Partners, Inc. has a 12 month low of $18.87 and a 12 month high of $33.90. The firm has a 50 day moving average of $22.46 and a two-hundred day moving average of $22.75.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The company had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. During the same period in the previous year, the firm posted $0.21 earnings per share. The company’s revenue for the quarter was up 8.4% compared to the same quarter last year. As a group, equities analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.